Zymeworks appointed Kristin Stafford as Chief Financial Officer at the Delaware-based biotechnology company. This is a routine senior management change with no financial details disclosed and is unlikely to materially affect the company’s outlook or share price.
Zymeworks appointed Kristin Stafford as Chief Financial Officer at the Delaware-based biotechnology company. This is a routine senior management change with no financial details disclosed and is unlikely to materially affect the company’s outlook or share price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment